CILENGITIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME AND UNMETHYLATED MGMT GENE PROMOTER: SAFETY RUN-IN RESULTS FROM A RANDOMIZED, CONTROLLED, PHASE II STUDY (CORE)

被引：0

作者：

Mikkelsen, T. ^{[1
]}

Nabors, L. B. ^{[2
]}

Fink, K. ^{[3
]}

Chan, M. ^{[4
]}

Trusheim, J. ^{[5
]}

Raval, S. ^{[6
,10
]}

Hicking, C. ^{[7
]}

Henslee-Downey, J. ^{[9
]}

Picard, M. ^{[7
]}

Reardon, D. ^{[8
]}

机构：

[1] Henry Ford Hlth Syst, Detroit, MI USA

[2] Univ Alabama, Neurooncol Program, Birmingham, AL USA

[3] Baylor Univ, Med Ctr, Dallas, TX USA

[4] Wake Forest Univ Hlth Sci, Winston Salem, NC USA

[5] Virginia Piper Canc Inst, Minneapolis, MN USA

[6] Monmouth Med Ctr, Long Branch, NJ USA

[7] Merck KGaA, Darmstadt, Germany

[8] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumour Ctr, Durham, NC USA

[9] EMD Serono Inc, Rockland, MA USA

[10] Garden State Neurol & Neurooncol, Long Branch, NJ USA

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：173 / 173

页数：1

共 50 条

[31] Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.
Tabatabai, Ghazaleh
Von Baumgarten, Louisa
Van Den Bent, Martin J.
Burger, Michael C.
Freres, Pierre
Glas, Martin
Hau, Peter
Herrlinger, Ulrich
Mildenberger, Iris
Neyns, Bart
Schafer, Henning Sebastian
Seidel, Clemens
Galot, Rachel
Wick, Antje
Falk, Martin H.
Chama, Laura Leticia de Freitas
Kelemen, Peter
Koch, Sven D.
Roche, Paula Romer
Gnad-Vogt, Senta Ulrike
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[32] Anlotinib for patients with newly diagnosed glioblastoma with unmethylated MGMT promoter: An open-label, single-center, phase 2 clinical trial.
Yang, Kunyu
Wu, Bian
Zhang, Zhanjie
Peng, Gang
Huang, Jing
Hong, Xiaohua
Ding, Qian
Shi, Liangliang
Wang, Xuan
Zhao, Hongyang
Jiang, Xiaobing
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] PHASE 1/2 STUDY OF DIANHYDROGALACTITOL (VAL-083) WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA
Chen, Zhong-ping
Guo, Chengcheng
Bacha, Jeffrey
Steino, Anne
Langlands, John
Kwan, Claire
Kanekal, Sarath
Schwartz, Richard
Lopez, Lorena
Brown, Dennis
NEURO-ONCOLOGY, 2018, 20 : 27 - 27
[34] CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN ADAPTIVE PLATFORM TRIAL
Rahman, Rifaquat
Trippa, Lorenzo
Fell, Geoffrey
Lee, Eudocia
Arrillaga-Romany, Isabel
Touat, Mehdi
McCluskey, Christine
Brunno, Jennifer
Gaffey, Sarah
Drappatz, Jan
Lassman, Andrew
Galanis, Evanthia
Ahluwalia, Manmeet
Colman, Howard
Nabors, Louis
Hepel, Jaroslaw
Elinzano, Heinrich
Schiff, David
Chukwueke, Ugonma
Beroukhim, Rameen
Nayak, Lakshmi
Mcfaline-Figueroa, Jose
Batchelor, Tracy
Rinne, Mikael
Kaley, Thomas
Lu-Emerson, Christine
Bi, Wenya Linda
Arnaout, Omar
Haas-Kogan, Daphne
Tanguturi, Shyam
Cagney, Daniel
Aizer, Ayal A.
Welch, Mary
Doherty, Lisa
Lavallee, Maria
Fisher-Longden, Brittany
Dowling, Shanna
Geduldig, Jack
Watkinson, Fiona
Santagata, Sandro
Meredith, David
Chiocca, E. Antonio
Reardon, David
Ligon, Keith
Alexander, Brian
Wen, Patrick
NEURO-ONCOLOGY, 2020, 22 : 43 - 44
[35] TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA
Tabatabai, G.
von Baumgarten, L.
van den Bent, M.
Burger, M. C.
Freres, P.
Glas, M.
Hau, P.
Herrlinger, U.
Mildenberger, I.
Neyns, B.
Schaefer, H.
Seidel, C.
de Vos, F.
Galot, R.
Whenham, N.
Wick, A.
Falk, M.
Chama, L. de Freitas
Henze, J.
Kelemen, P.
Koch, S. D.
Lutz, J.
Heidenreich, R.
Roche, P. Romer
Rost, T.
Schoenborn-Kellenberger, O.
Gnad-Vogt, U.
NEURO-ONCOLOGY, 2023, 25 : 47 - 47
[36] Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082)
Wick, Wolfgang
Gorlia, Thierry
Bady, Pierre
Platten, Michael
van den Bent, Martin J.
Taphoorn, Martin J. B.
Steuve, Jonathan
Brandes, Alba A.
Hamou, Marie-France
Wick, Antje
Kosch, Markus
Weller, Michael
Stupp, Roger
Roth, Patrick
Golfinopoulos, Vassilis
Frenel, Jean-Sebastien
Campone, Mario
Ricard, Damien
Marosi, Christine
Villa, Salvador
Weyerbrock, Astrid
Hopkins, Kirsten
Homicsko, Krisztian
Lhermitte, Benoit
Pesce, Gianfranco
Hegi, Monika E.
CLINICAL CANCER RESEARCH, 2016, 22 (19) : 4797 - 4806
[37] Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study
Nicholas, M. K.
Lucas, R. V.
Arzbaecher, J.
Paleologos, N.
Krouwer, H.
Malkin, M.
Omar, A.
Vick, N. A.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[38] PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation A Randomized Phase II Study: BrUOG 244
Elinzano, Heinrich
Glantz, Michael
Mrugala, Maciej
Kesari, Santosh
Piccioni, David E.
Kim, Lyndon
Pan, Edward
Yunus, Shakeeb
Coyle, Thomas
Timothy, Kinsella
Evans, Devon
Mantripragada, Kalyan
Boxerman, Jerrold
DiPetrillo, Thomas
Donahue, John E.
Hebda, Nicholas
Mitchell, Kristen M.
Rosati, Kayla L.
Safran, Howard
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (02): : 159 - 162
[39] A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548
Weller, Michael
Lim, Michael
Idbaih, Ahmed
Steinbach, Joachim
Finocchiaro, Gaetano
Raval, Raju
Ashby, Lynn
Ansstas, George
Baehring, Joachim
Taylor, Jennie
Honnorat, Jerome
Petrecca, Kevin
De Vos, Filip
Wick, Antje
Sumrall, Ashley
Roberts, Mustimbo
Slepetis, Ruta
Warad, Deepti
Lee, Michelle
Reardon, David
Omuro, Antonio
NEURO-ONCOLOGY, 2021, 23 : 55 - 56
[40] A PHASE II TRIAL OF CONCURRENT SUNITINIB, TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS WITH AN UNMETHYLATED MGMT GENE PROMOTER (A01-M121-11A, MCG1132)
Faye, Mame Daro
Sabri, Siham
De Robles, Paula
Easaw, Jacob
Agnihotram, Raman
Torres-Vasquez, Alexander
Panet-Raymond, Valerie
Shenouda, George
Souhami, Luis
Abdulkarim, Bassam
RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S5 - S5

← 1 2 3 4 5 →